Scott Cheryl
SEC insider (Form 3/4/5 filer). CIK 0001656979. Director at Progyny, Inc. (PGNY) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in NEW YORK, NY.
Companies Scott Cheryl has filed insider reports for
- Progyny, Inc. (PGNY): Director
- Evolent Health, Inc. (EVH): Director
Scott Cheryl
CIK: 0001656979
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (28.6%)
Position reduction
Option Exercises (M)1 (14.3%)
Derivative conversions
Awards (A)3 (42.9%)
Compensation grants
Other (G, F, J, C, D, …)1 (14.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 1, 2026PGNY
Progyny, Inc.
Tax PaymentDirect7.2K shares at avg. $26.38$191K - Jun 1, 2026PGNY
Progyny, Inc.
ExerciseDirect14.7K shares at avg. $13.00$191K - Jun 1, 2026PGNY
Progyny, Inc.
SaleDirect7.4K shares at avg. $26.39$196K - May 21, 2026PGNY
Progyny, Inc.
AwardDirect5.7K shares- - Jun 11, 2025PGNY
Progyny, Inc.
SaleDirect2.7K shares at avg. $22.07$59K - Jun 5, 2025EVH
Evolent Health, Inc.
AwardDirect22K shares- - May 22, 2025PGNY
Progyny, Inc.
AwardDirect6.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 1, 2026 |  PGNY Progyny, Inc. | Tax Payment | 7,228 | $26.38 | $190,675 | Direct |
| Jun 1, 2026 | PGNY Progyny, Inc. | Exercise | 14,667 | $13.00 | $190,671 | Direct |
| Jun 1, 2026 | PGNY Progyny, Inc. | Sale | 7,439 | $26.39 | $196,278 | Direct |
| May 21, 2026 | PGNY Progyny, Inc. | Award | 5,660 | - | $0 | Direct |
| Jun 11, 2025 | PGNY Progyny, Inc. | Sale | 2,675 | $22.07 | $59,037 | Direct |
| Jun 5, 2025 |  EVH Evolent Health, Inc. | Award | 21,979 | - | - | Direct |
| May 22, 2025 | PGNY Progyny, Inc. | Award | 6,689 | - | - | Direct |
1-7 of 7 transactions